Russia to roll out its first approved COVID-19 drug next week
Russian hospitals can begin giving the antiviral drug, which is registered under the name Avifavir, to patients from June 11, the…
Author
New coronavirus losing potency, top Italian doctor says
Italy has the third highest death toll in the world from COVID-19, with 33,415 people dying since the outbreak came to light on…
Celltrion says COVID-19 drug shows drop in viral load in animal testing
Celltrion has research experience with other types of coronavirus conditions such as Middle East Respiratory Syndrome (MERS)
30 countries launch initiative to share COVID-19 tools
It comes amid concerns that rich countries pumping resources into finding will muscle their way to the front of the queue, once a…
Pfizer ties up with glass maker Corning for vial supply
Pfizer, like rivals Merck & Co and AstraZeneca, is racing to develop a vaccine for COVID-19, the illness caused by the novel…
EU plans permanent stockpile of essential drugs, medical gear
The stockpile would be funded from a new health budget worth 9.4 billion euros ($10.3 billion) which the EU executive commission…
AstraZeneca says it may consider exposing vaccine trial participants to virus
The British drugmaker last week started phase 2 and 3 trials of the vaccine, looking to recruit around 10,000 adults and children…
US FDA asks five firms to recall diabetes drug with high NDMA levels
It named Apotex Corp as one of the firms whose metformin tablets have high levels of NDMA, but did not reveal the other four firms
Novartis inks deal to make Mass General Brigham’s COVID-19 vaccine candidate
AveXis, which makes Novartis’s $2.1 million-per-patient gene therapy Zolgensma for the hereditary disease spinal muscular atrophy,…
GSK says science does not link pandemic H1N1 flu vaccine to sleep disorder
A spokesman for GSK said the “science has moved on” since concerns were raised about links between narcolepsy and its H1N1…